Literature DB >> 12521830

Three decades of acquired gynaetresia in Ibadan: clinical presentation and management.

A O Arowojolu1, M A Okunlola, A O Adekunle, A O Ilesanmi.   

Abstract

A retrospective analysis of acquired gynaetresia (Vaginal Stenosis) managed at the University College Hospital Ibadan, Nigeria between 1967 and 1996 was conducted in terms of clinical presentation and management. The prevalence rate was 7/1000. The peak age incidence was 20-30 years. Chemical vaginitis resulting from insertion of caustic vaginal pessaries for various reasons was the major cause of acquired gynaetresia. Dyspareunia/apyreunia and vaginal stenosis/occlusion were the most common symptoms and clinical findings respectively. The various surgical treatment of acquired gynaetresia included one stage vaginoplasty, McIndole-Read's two stage vaginplasty, separation of labial agglutination, Williams's operation, and simple dilatation of the vagina. Successful correction was recorded in 68% of the patients while 28% had residual partial stenosis, 4% had complete stenosis and 6% were lost to follow-up. It was concluded that acquired gynaetresia is preventable. Efforts should be made by authorities to address this issue and create designated centres in the country for the management of these cases and training of junior gynaecologists.

Entities:  

Year:  2001        PMID: 12521830     DOI: 10.1080/01443610120059923

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  3 in total

1.  Postpartum Vaginal Stenosis Due to Chemical Vaginitis.

Authors:  Gurcharan Kaur; Maruti Sinha; Ridhima Gupta
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Acquired gynatresia.

Authors:  Shipra Kunwar; Tamkin Khan; Hemprabha Gupta
Journal:  BMJ Case Rep       Date:  2014-04-28

3.  Successful pregnancy following acquired gynatresia.

Authors:  Amina Gambo Umar; Yakubu Ahmed; Jamila Abubakar Garba; Abdullahi Umar Adoke; Abdulhadi Diyo Saidu; Mairo Hassan
Journal:  Ann Afr Med       Date:  2019 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.